Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2025 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2025 Earnings Call Transcript May 6, 2025Harmony Biosciences Holdings, Inc. beats earnings expectations.
Harmony Biosciences Holdings Inc. (HRMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 144,244 | $4,787,458 | -53% | 0.04% |
| 2. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 91,301 | $3,030,280 | -25% | 1.34% |
| 3. | Royce & Associates Chuck Royce | 81,759 | $2,713,581 | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.00 | 339,476 | Large Shareholder | 10,651,120 | 2020-08-21 | Filing | |
| $34.30 | 3,922 | Director | 42,702 | 2020-08-26 | Filing | |
| $34.20 | 823 | Director | 38,780 | 2020-08-25 | Filing | |
| $24.00 | 132,503 | Large Shareholder | 4,409,803 | 2020-08-21 | Filing | |
| $34.30 | 3,057 | Director | 37,957 | 2020-08-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.12 | 740 | 0 | 2025-04-01 | Filing | ||
| $32.48 | 6,247 | 740 | 2025-04-01 | Filing | ||
| $33.23 | 500 | 0 | 2025-03-03 | Filing | ||
| $32.61 | 4,369 | 500 | 2025-03-03 | Filing | ||
| $38.02 | 1,629 | 0 | 2025-01-27 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,511,873 | $216,129,064 | 0% | |
| 2. | 4,699,353 | $155,971,526 | 0% | |
| 3. | 753,547 | $25,010,225 | 0.01% | |
| 4. | 496,959 | $16,494,069 | 0.04% | |
| 5. | 466,072 | $15,468,930 | 0% |
News See All
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory
We came across a bullish thesis on Harmony Biosciences Holdings, Inc. (HRMY) on Value Investing Subreddit Page by Long-Access-2143. In this article, we will summarize the bulls’ thesis on HRMY.
10 Best Small-Cap Stocks to Buy Before They Explode
Since the announcement of tariffs, investors have been concerned regarding the market volatility.
10 Cash-Rich Small Cap Stocks To Invest In According To Analysts
Small-cap stocks in the US have been under pressure, with the Russell small cap index falling 10% from its November highs as of January 2025.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2024 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2024 Earnings Call Transcript February 25, 2025Harmony Biosciences Holdings, Inc. beats earnings expectations.
10 Best Small-Cap Growth Stocks to Buy Now
On November 4, 2024, Nick Sheridan, Portfolio Manager at Janus Henderson released a report on small-cap stocks exploring how these stocks offer unique growth and diversification opportunities.
10 Oversold Biotech Stocks to Buy Now
Biotechnology stocks are among the most volatile in the market, primarily due to the high risks associated with their performance.
10 Cheap Biotech Stocks to Invest in Now
Biotechnology stocks are among the most volatile in the market due to their high risk.
Top 10 Small Cap Stocks to Buy with the Highest Upside Potential
On December 30, MJP Wealth Advisors chief investment officer Brian Vendig appeared on Yahoo! Finance's Catalysts to discuss the potential outlook of small cap stocks in 2025.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2024 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2024 Earnings Call Transcript October 29, 2024Harmony Biosciences Holdings, Inc. beats earnings expectations.
Billionaire Hedge Funds
